3.2. Graphene and Related Materials as Drug Delivery Platforms
The most investigated biological application of graphene and related materials’ still remains drug delivery [
91]. The ability of materials to drag and drop chemicals in the human body environment is well exploited by graphene and graphene-related materials [
81].
Zhang et al. [
92] described the interactions between graphene and proteins elucidating the ability of graphene-based materials to trigger several protein complexes on the cellular membrane to facilitate uptake. This was due to both electron transfer and residual functionalities on graphene-like materials’ surface. Wang et al. [
93] deeply explored the relationship between graphene’s surface topological defects and its ability of drug delivery, proving a strong effect of topology. The authors described the folding ability of these materials in several shapes ranging from nanoscrolls to polyhedral ones. This protean ability allows different interactions with different folding agents such as membrane proteins or nucleic acids. A further study by Mohammed et al. [
94] theoretically clarified the loading ability of pristine and metal-decorated graphene materials. Among them, hydrogel and foam are the most attracting solutions because drug release could be triggered by both chemical and thermal modifications [
95].
Ezzati et al. [
96] produced a biocompatible graphene foam surface tailored with alanine, cysteine, and glycine for cisplatin drug and release. The authors tested the material with a high load of cisplatin on MCF-7 and HepG2 human cancer cell lines with good results. Additionally, the graphene-based carrier underwent biodegradation inside the body according to the mechanism reported in
Figure 2.
Authors clearly described that after cellular death the graphene foam was degraded by both reactive oxygen radicals and hydrolytic enzymes. Furthermore, the degradation pathway lead to the formation of carbon dioxide without highly toxic metabolites.
Abdel-Bary et al. [
97] studied the release of cisplatin in a very complex graphene-based system containing chitosan, magnetite, and silicon dioxide. By a combination of empirical studies and density functional theory calculation, authors showed that the presence of graphene improved the releasing potentiality up to 91% compared with the other samples tested.
Graphene and related materials also represent a very promising platform for drug release upon biological stimuli, as reported by Trusek et al. [
98] in the case of doxorubicin.
Doxorubicin is a widely diffused anticancer drug acting on the S phase of the cellular metabolic pathway [
99]. Several studies reveal the efficacy of graphene-based materials as carriers for doxorubicin as reported by Shen et al. [
100]. Contrary to polymer-based formulations, graphene and graphene-like materials could act not merely as delivery systems but also as smart platforms to target and release doxorubicin upon several stimuli on a large time window and to monitor the cell vitality [
101]. Furthermore, graphene-like materials could be also coupled with polymers to enhance classical formulation effects. The authors proved the effectiveness of chitosan-tailored graphene materials as carriers through molecular dynamic calculation. Doxorubicin interacts with both the π orbital system of graphene and the polar functionalities of the chitosan. After reaching the target, doxorubicin interacts with protein amine and carboxylic residues losing the chitosan interactions. In this case, the weak interactions with the graphene surface are not sufficient, and it was efficiently released.
This effect was magnified considering that the base of the drug delivery systems is the pH release mechanism [
102].
Anirudhan et al. [
103] described a pH-responsive, GO-based functionalized chitosan nanocomposite for doxorubicin delivery. This system was tailored with folic acid and chitosan through dicyclohexylcarbodiimide coupling using ethyleneglycol dimethacrylate as the cross-linker and potassium peroxydisulphate as an initiator to generate carboxylates able to react with chitosan. The authors loaded the drug by π–π stacking interactions, reporting a loading capacity of up to 95% and a high release rate at pH 5.3. This was particularly attractive for cancerous cell lines with an acidic microenvironment such as L929, HeLa, and MCF7. In vitro tests showed promising results in decrementing their proliferation. Similarly, Omidi et al. [
104] developed an innovative pH-sensitive, injectable hydrogel composed by combining chitosan, GO, and cellulose nanowhiskers for the co-delivery of doxorubicin and curcumin that was also studied by Pourjavadi et al. [
105]. Authors combined GO with hyperbranched polyglycerol and grafted it with chlorine-based and hydrazine pendants. In this study, doxorubicin was loaded onto the graphene-based carrier by covalent bonding with the hydrazine pendant group, and curcumin was loaded through π–π stacking with GO sheets. The authors claimed a superior biocompatibility together with an improvement of drug internalization. Alipour et al. [
106] described an interesting material based on ZnO/dopamine-tailored GO for the enhanced delivery of doxorubicin. The authors evaluated the cytotoxicity of the graphene-based nanohybrid against T47D and MCF10A cellular lines showing a good efficacy together with an antimicrobial activity against Gram-positive and -negative bacteria.
Sattari et al. [
107] extended the graphene co-delivery systems’ application by the conjugation of GO with cyclodextrins and chitosan fibres for the production of a multidrug loading system. The authors loaded gallic acid and curcumin showing anti-cancer, antimicrobial, antioxidant, and anti-inflammatory activities, which was quite challenging in the absence of graphene-like materials, requiring sophisticated encapsuling procedures [
108]. As an alternative to co-delivering, the modification of graphene materials could be a solid choice to enhance the anticancer activity. Jahanshahi et al. [
109] produced a highly fluorinated graphene by treating a graphene precursor in an acidic ionic liquid showing a 20% improvement of curcumin loading without compromising the release efficiency. Similarly, Razaghi et al. [
110] synthesized fluorinated GO nanosheets able to deliver linoleic–curcumin conjugate and useful for T
2-weighted magnetic resonance imaging. The authors showed that accumulation in the MCF-7 cell line was strictly dependent on pH, and the effectiveness increased moving on to MCF-10A line. Additionally, the authors estimated the relaxation rate as 67.12 (smM)
−1 and with the very attracting ability to reduce signal intensity in the presence of MCF10A and MCF-7 cells. In vivo studies showed a tumour cell suppression using 4T1 cell line. Zaboli et al. [
111] functionalized GO with dopamine altering the surface properties of GO and improving the drug-ability of cytarabine. This tailoring process was modelled by using the DFT approach showing the relevance of orbital interaction during the overall drug loading and release process.
Injectable formulations of graphene-related materials are not the only approach to drug delivery. Li et al. [
112] produced a membrane based on GO and Pluronic
® F127 for the transdermal delivery of ondansetron. The authors produced a hydrogel with good mechanical properties for topical application, suggesting that the drug flux proportionally decreased with the increase in the level of GO in the hydrogel due to π–π stacking interaction decrement. This meant that the drug release rate can be tuned by tuning the amount of GO as clearly showed by bioavailability tests run on rat models. A GO membrane was also used by Shahabi et al. [
113] for delivering tegafur. Molecular dynamics simulation confirmed the strong interaction between GO and drug as mentioned before due to both weak interactions and hydrogen bonds.
Moving forward, graphene and its related materials could be used to drag and drop antibiotics and antimicrobial agents. Abdoli et al. [
114] combined poly(vinyl alcohol), tragacanth gum, and GO composite nanofibre for tetracycline delivery, preserving the activity of the antibiotic and controlling the release in time. Authors tested the cytotoxicity against HUVECs as well as agar disk diffusion to determine the antibacterial activity. The cytotoxicity assay showed a high cell viability while antibacterial activity was interestingly high. The buccal administration of clotrimazole though a GO-based formulation was reported by Huang et al. [
115]. The authors reported an increased clotrimazole release from the GO films in vitro at up to pH 6.8. Furthermore, they reported an increased activity against
Candida albicans.
GO-based systems were also used for the delivery of ketamine [
116], ibuprofen [
117], and medicine for hormone therapy [
118]. In all cases, the high control on drug release prevented the sudden increment of drugs, leading to a time-prolonged release.
3.3. Graphene and Related Materials as Tool for Regenerative Medicine and Tissue Repair
The combination of graphene and graphene derivatives with plenty of different matrices has represented a game changing event in the production of biomaterials [
119,
120]. Fixing or replacing both tissues and organs has been boosted by the graphene-based composites by combining biocompatible scaffolds due to a variety of surface interactions [
121].
Tissue engineering is one of the frontiers of medicine, aiming to overcome the drawbacks of the classical transplant procedure through the production of hybrid materials able to perform the same activity as the tissues replaced [
122]. Graphene and its related materials have shown very attractive results related to the production of polymeric composites with great mechanical performances together with high biocompatibility for several applications ranging from bone to soft tissue repair [
123].
Bahrami et al. [
124] combined polyurethane with graphene for the production of conducting-polymer-based-material tissue regeneration. The authors aimed to grow L929 fibroblast and blood vessel endothelial cells on a membrane containing graphene flakes. This was particularly interesting in the case of endothelial cells. Indeed, they could be grown on the inner surface of tubular scaffolds by mimicking the native blood vessel structure [
74]. The authors proved the ability of composites to support the attachment, spreading, and proliferation of cell lines. A very close approach was used by Pant et al. [
125] for the production of coated stents by using graphene oxide mixed with polyurethane.
As shown in
Figure 3, graphene-oxide-based composites create a stable coating on the surface of the stent without any tearing or ablation phenomenon.
The modification of interphase properties due to the presence of graphene clearly increased the durability of the stent due to the radical-scavenging effect, which preserves the polymeric matrix from degradation promoted by extracellular fluids.
Similar results could be achieved by using titanium-based materials [
126], which however show the critical drawback of cellular morphology alteration.
Pathmanapan et al. [
127] dispersed graphene oxide into fibrin hydrogel as scaffolds for bone repair proving an enhanced level of biocompatibility, alkaline phosphatase activity, and calcium deposits. This was particularly interesting due the difficulty of solid bone repairing by using polymeric composites and could lead the way to avoid the use of metal alloys [
128], preventing the vicious effects related to metal release [
129].
Khalili et al. [
130] studied the use of an electroactive poly (p-phenylene sulphide)/chitosan mixed with rGO as a potential candidate for tissue engineering. These authors found that high biocompatibility was reached by using an rGO loading of up to 10 wt.% proving a cell attachment and a general porosity of up to 80%. Chitosan was also used in combination with GO and calcium silicate to produce a hierarchical microstructured biomaterial for wound dressing [
131]. The authors aimed to reproduce the orderly, porous, lamellar micron-scale structure of a healing wound, producing a material acting as wound dressing. It was also able to induce photothermal antibacterial and antitumour activity together with wound healing. Wang et al. [
132] moved a step forward and combined GO with silk’s proteinaceous structure. Silk fibroin materials embedding GO showed an improvement of both mechanical and thermal properties of silk biomaterials, reaching a Young’s modulus of up to 1.65 GPa by using only 0.5 wt.% of filler. By in vivo studies, authors showed the improved cell adhesion, growth, and proliferation of fibroblast cells. Graphene and its related materials have boosted the use of poly(lactic acid) (PLA) as matrix for bone repair and tissue engineering [
133]. Marques et al. [
134] combined PLA with GO and hydroxyapatite for the production of a high hardness and storage modulus, showing an efficient load transfer between the fillers and the polymeric matrix. These results outperformed those achieved by simply using polyglicolides stereocomplexes [
135,
136] and inorganic composites [
137]. Furthermore, PLA/poly(caprolactone) (PCL) blends have been used by Chiesa et al. [
138] for the preparation of electrospun fibres with high biocompatibility and a compatible morphology with bone engineering. Poly(ethylene) is another solid solution for the production of biomaterials containing graphene and related materials. Lahiri et al. [
139] dispersed graphene nanoplatelets into ultrahigh-molecular-weight poly(ethylene) for orthopaedic implants by using an electrostatic spraying technique. The authors reported that a graphene concentration of up to 0.1 wt.% induced an improvement of fracture toughness of up to 54% and tensile strength increment of up to 71%, while a filler concentration of 1 wt.% increased the elastic modulus and yield strength with a significant decrement of all other properties. The cytotoxicity of graphene nanoplates to osteoblasts was tested, and the authors showed that it is dependent on concentration and graphene agglomeration. Osteoblasts’ survival decreased by up to 86% by using composites loaded with 1 wt.% filler, while composites with only 0.1 wt.% of graphene showed a survival reduction of only 16%.
Similarly, Upadhyay et al. [
140] studied high-density PE with GO by melt mixing, followed by compression moulding. The uniform dispersion achieved was a key point for the biocompatibility as mentioned before, and the authors achieved an optimum GO dispersion by immobilizing them on the PE surface through nucleophilic addition–elimination reaction. Authors achieved a yield strength of up to 20 MPa, an elastic modulus around 600 MPa, and an elongation-at-failure improvement of up to 70% by using a filler loading of up to 3 wt.%. Furthermore, authors successfully evaluated both the proteins’ adsorption on the surface of composites and biophysical precursor process of cell adhesion by using serum albumin. As mentioned before, the presence of a small amount of graphene could dramatically improve the protein interaction on the interphase. Additionally, authors grew osteoblast and human mesenchymal stem cells lines on the composites by showing a significant increase in metabolic cell activity and proliferation.
The other interesting class of biomaterials based on graphene and its related derivatives is represented by metal alloys [
141]. Graphene promoted the strengthening mechanism of metal alloys due to its excellent bonding interfaces compared with that of traditional alloys [
142]. There are still many challenges on the board such as the dispersion of graphene and its related materials into a metal matrix, which is generally done through chemical [
143] or mechanical mixing [
144] and electrode deposition methods [
145]. All of these composites have found interesting biological applications [
146].
Escudero et al. [
147] electrochemically used rGO for the production of a cobalt/chromium alloy revealing an sp
2 bonding together with the presence of oxygenated groups at the interphase between rGO and the metal matrix. The authors tested the biocompatibility of this material by using mouse macrophage J774A.1 cell line, monitoring the ratio between lactate dehydrogenase and mitochondrial activities. Compared with the neat CoCr alloy, the rGO-based composite promoted the presence of well-distributed and well-shaped macrophages. Additionally, vimentin expression was unaltered, proving the enhanced biocompatibility. In vivo tests were run by survivor ability intraperitoneal injection in Wistar rats. The primary interaction with red blood cells showed a reduction of their size raising some concerns about the in vivo properties.
Nonetheless, coatings produced by using GO have been used by Gao et al. [
148] to reduce the corrosion rate of magnesium alloy. Magnesium alloys are ideal materials for cardiovascular stents, but they are prone to corrosion [
149]. The authors proved that a chitosan/heparinized GO multilayer coating enhanced the corrosion resistance by reducing the haemolysis rate and platelet adhesion and promoting the adhesion and proliferation of endothelial cells.
Golzar et al. [
150] used a similar approach by producing GO/magnesium nanohybrids for enhancing the osteoinductive capability of 3D-printed calcium phosphate-based scaffolds. This material aimed to be highly compatible with dental pulp stem cells. Authors firstly modified rGO by combining it with gelatine and mixed it with phosphates. Then, an enhancement of mechanical features, cell proliferation, and differentiation is achieved. Furthermore, they observed an up-regulation of bone-related genes and proteins COL-I, RUNX2, OCN.
Shahin et al. [
151] confirmed the suitability of graphene and magnesium for the production of orthopaedic hard-tissue replacement applications. By only a 0.1 wt.% of graphene nanoplates mixed with magnesium and zirconium, authors observed an improvement of wear resistance by 92% at 200 µN and a reduction of both wear depth and coefficient of friction of the alloy.
Lascano et al. [
152] reported a step forward in the use of graphene and its related composites for tissue engineering applications. The authors produced a spongy Nb–Ta–xMn alloy (x: 2, 4, and 6 wt.%) coated with graphene/Ti alloy, reducing the cytotoxicity and improving the biocompatibility upon that of uncoated material. Moreover, in this case, graphene coating improved the cell adhesion and proliferation without compromising the cell morphology.
Su et al. [
153] went in deep in the topic by studying the osteoimmunomodulatory role to enhance osteogenesis of titanium coated with GO. The authors evaluated the ability to stimulate the expression of osteogenic genes and extracellular matrix mineralization in human mesenchymal stromal cells. They found that GO-coated surfaces could induce the polarization of macrophages and expression of inflammatory cytokines via the Toll-like receptor pathway. In vivo, GO-coated titanium activated macrophages and induced mild inflammation and a pro-osteogenic environment, with a slight increase in the levels of proinflammatory cytokines. In the meanwhile, an improved expression of TGF-β1 and oncostatin M genes is verified.
Li et al. [
154] proposed an interesting application for sintered rGO flakes and liquid rGO/titania material as a synthetic keratoprosthesis skirt for end-stage corneal disorders. These authors observed an improvement of mechanical and chemical properties together with a better wear and corrosion resistance for a loading of 1 wt.%. In vivo studies were carried out by implanting to rabbit corneas without observing any immune and inflammatory responses.
Regenerative medicine is another field where graphene-based materials have released their full potential [
155,
156]. The adherence of a cell on graphene is a critical property as shown by Morçimen et al. [
157]. By studying the adherence and proliferation of the SH-SY5Y neuron cell line on graphene foams, authors proved the viability of this approach in more complex procedures.
Feng et al. [
158] produced an iron-oxide-based, magnetic, electrospun, short nanofibre-wrapped GO for a guiding cellular behaviour as shown in
Figure 4.
As shown in
Figure 4, the authors produced short GO magnetic fibres by electrospinning techniques achieving materials with diameters of up to 300 nm and a length of up to 80 μm and a magnetization saturation of up to 50.33 emu/g. These fibres were able to induce an extremely tight adhesion with cells due to the functionalized GO. The observations were particularly promising for tissues manipulation by using external magnetic fields to selectively move specific cellular groups by tailoring the GO surface. Furthermore, the creation of controlled cellular aggregates could be a step forward in specific site repairing.
Agarwal et al. [
159] produced a highly elastic and electroconductive graphene/collagen cryogel for spinal cord regeneration. Firstly, the authors tailored the graphene surface with amine residues promoting an efficient cross-linking with collagen showing a conductivity of up to 3.8 ± 0.2 mS/cm and a Young modulus of up to 347 kPa. The authors tested this composite for stem cell transplantation and neural tissue regeneration through the cryogelation approach by using the BM-MSCs cell line. They reported a good stem cell growth and expression enhancement of
CD90 and
CD73 gene upon electric stimulation of up to 100 mV/mm without the loss of stemness. Additionally, the authors observed an ATP secretion increment that could be helpful to favour neuronal regeneration and immunomodulation. Graphene-based cryogel promoted the neuronal differentiation of BM-MSCs with enhanced expression of MAP-2 kinase and β-tubulin III. In vitro observation proved a high indoleamine 2,3 dioxygenase activity under inflammatory conditions together with the proliferation of macrophages, which could aid in tissue repair.
Cellular proliferation is the other relevant task to be faced. Sekuła-Stryjewska et al. [
160] studied both GO and rGO as promoting agents for the cardiomyogenic and angiogenic differentiation capacity of human mesenchymal stem cells in vitro. The authors showed that, generally, those substrates fit the requirements for cellular proliferation with the exception of small GO flakes and highly reduced rGO, which decreased proliferation by inducing apoptosis. Nonetheless, this study proved that both GO and rGO did not alter stem cells’ phenotype and cell cycle progression while they could tune their adhesive capabilities of these cells. These properties could be used in ocular regenerative medicine as reported by Zambrano-Andazol et al. [
161] as a sound replacement for functionalized hydrogels [
162].
Ginestra et al. [
163] realized poly(caprolactone) mixed with graphene for nerve tissue engineering through electrospinning. Nanofibrous composites showed good properties for the proliferation of rat stem cells with a preferential differentiation to dopaminergic neuronal cells with the increment of graphene percentage.
Similarly, Polo et al. [
164] produced nanostructured scaffolds based on copolymers (poly(lactic acid)-poly(caprolactone)) containing GO, aiming to induce the aligned migration and accelerate the neuronal differentiation of neural stem cells. Authors proved the ability to re-establish the spatially oriented neural precursor cell connectivity of this material.
Park et al. [
165] used the highly conductive properties of graphene-based hydrogel for the realization of artificial muscles. The hydrogel was produced by incorporating GO into poly(acrylamide) using femtosecond laser ablation and a chemical reduction. In vitro studies with C2C12 myoblasts revealed that the micropatterned graphene hydrogel induced the myogenesis and myotube alignment. In vivo implantation studies showed a good tissue compatibility.
Techaniyom et al. [
166] showed that osteoblast differentiation and gene expression could also be modulated by GO coating of titanium materials due to an upregulation of the expression of the bone matrix protein genes during late-stage osteoblast differentiation.
3.4. From Material to Supramolecular Cluster: Graphene Quantum Dots
Graphene and its related derivatives lack of some properties such as bandgap or optical properties. This reduces the possible applications, and an engineered material could offset these limitations. In recent times, graphene quantum dots (GQDs) have received great attention for their possible unique applications [
167] as a solid alternative to classical graphene, GO, and rGO.
Graphene quantum dots consist of graphene sheets, which could be single-sheet or multi-layered. They are nanoparticles with dimensions smaller than 100 nm, commonly under 20 nm, and their shapes are usually circular or elliptical. However, other shapes are produced with different synthetic routes [
168].
The synthesis methods to produce GQDs are both top–down and bottom–up as summarized in
Figure 5 by using different precursors and synthetic strategies.
The most common approach is the top–down one that usually consists of physical processes that reduce the dimensions of carbon materials as carbon fibres [
170] or coal [
171], along with acid oxidation [
172] and hydrothermal treatment [
173]. Solvothermal route [
174], microwave [
175], and sonication [
176] are also promising alternative approaches.
A top–down physical process is the acid exfoliation, followed by the oxidation of the nano-obtained product. Li et al. [
177] suggested an electrochemical synthesis route to produce a variety of GQDs, although the products differ in size, emission colours, and other intrinsic properties. Hydrothermal synthesis can be done just on precise precursors, such as GO, with a functionalization with oxidizing agents to introduce functional groups on the product surface [
178].
The bottom–up method provides for the generation of aromatic molecules as precursors and can lead to high yield. Li et al. [
179] developed a protocol to fabricate GQDs through direct pyrolysis on citric acid.
The synthesis routes mentioned above lead to a differentiation of the GQDs produced and their different physicochemical properties which depend on procedure, precursors, defects, and functional groups [
180,
181]. The GQDs’ properties of interest are absorbance, photoluminescence (PL), electrochemical photoluminescence among the optical ones and of course their biocompatibility; all these properties make them great candidates for bioimaging and theragnostic applications.
The absorption characteristics of GQDs are shown in the short-wavelength region because of C=C bonds and around 270–390 nm they show peaks for the C=O bonds. The passivation of the surface with a functional group can alter the disposition of the peaks; it strongly depends on the type of dot.
The principal and most fascinating property of the carbon dots is their photoluminescence. The unclear photoluminescence mechanism is one of the impediments to understand completely the physical mechanism behind these promising materials. The tuneable property of photoluminescence is size-dependent since it is related to quantum confinement. Moreover, other factors such as shape, defect, and doping also influence the effect. In detail, Zhu et al. [
182] reported that PL is related to the quantum confinement effect of the electrons in sp
2 carbons [
183]. Another structure-dependent characteristic of GQDs is the electron transfer [
184]. Biocompatibility and almost absent toxicity make them eligible for in vivo applications. In vitro studies have been made by Shang et al. [
185], and they studied the GQDs’ effects on the cellular life finding out how the nanomaterial did not affect either the viability or the reproduction capacity. In vivo studies have been made on mice by exposing them to different nanomaterials. The results showed no abnormalities in organs or habits and brought to awareness their excellent biocompatibility, raising interest in the possible bio-applications.
The possible bio-applications of GQDs are cellular imaging [
186], real-time in vivo biosensing [
187], and drug delivery [
188].
The main advantages of GQDs upon traditional imaging solution is related to the extremely high biocompatibility together with facile tailoring properties. Furthermore, the metabolic excretion after the procedure promotes a rapid removal of toxic formulation elements, e.g., heavy metals such as gadolinium or europium used in imaging procedures [
189].